Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefiderocol PK in Critically Ill Patients on CRRT
NCT05373615Phase 1Completed
- Sponsor
- Hartford Hospital
- Start
- Jul 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cefiderocol in bacterial infection, sponsored by Hartford Hospital. Primary endpoints: Cefiderocol concentration, Cefiderocol clearance and 1 more. Started Jul 2022; status: completed.
02
Drugs
cefiderocol
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05373615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05373615.